XORTX Appoints New Director
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company focused on therapies for gout and kidney disease, announced the appointment of Depesh Narotam as an independent director on its board. Mr. Narotam brings over 20 years of financial services experience and will serve on the Compensation, Governance and Nominating Committee. The co…